DOCSLIB.ORG

An Inventory & Environmental Scan of Evidence-Based Practices For

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
An Inventory & Environmental Scan of Evidence-Based Practices For An Inventory & Environmental Scan of Evidence-Based Practices for Treating Persons in Early Stages of Serious Mental Disorders Updated: October, 2017 Developed for SAMHSA by NASMHPD and NRI JBS Contract Reference: HHSS283201200002I/Task Order No. HHSS28342002T Contents Note Regarding 2017 Update: ................................................................................................................................2 Introduction ................................................................................................................................................................2 Overview of EBP Inventory and Environmental Scan .................................................................................................3 Methodology ..............................................................................................................................................................4 Limitations ..................................................................................................................................................................6 Matrix A: Examples of Coordinated Care Models for Persons in Early Stages of Illness ............................................7 Matrix B: Examples of Individual Evidence-Based Practices ................................................................................... 26 Selected Additional Resources ................................................................................................................................ 37 Resources Focusing on Early Intervention in Schizophrenia and other Psychotic Illnesses ............................... 37 Federal Agencies .................................................................................................................................................. 37 Directories of Early Intervention Programs ......................................................................................................... 38 Organizations/Networks Addressing Early Psychosis .......................................................................................... 39 Archived Webinars ............................................................................................................................................... 40 Citations for Selected Peer-Reviewed Articles and Books of Relevance.............................................................. 50 Resources Focusing on Depression and Bipolar Disorder ................................................................................... 74 General Mental Health Resources of Relevance for First Episode Programs ..................................................... 77 Early Diagnosis and Preventive Treatment (EDAPT) & Sacramento EDAPT (SacEDAPT) ..................................... 81 FIRST Early Identification and Treatment of Psychosis Program ......................................................................... 83 The BeST Center is providing FIRST program training, consultation and technical assistance to the community mental health agencies in Ohio that received Mental Health Block Grant five percent set-aside funds to establish first episode psychosis programs. ......................................................................................................... 86 RAISE Connection Model at the University of Maryland Medical Center and School of Medicine ..................... 87 NAVIGATE RAISE Early Treatment Program (ETP) ................................................................................................ 91 OnTrackNY ............................................................................................................................................................ 96 Early Assessment and Support Alliance (EASA).................................................................................................. 102 Felton Early Psychosis Program (formerly called PREP) ..................................................................................... 106 University of North Carolina Outreach and Support Intervention Services (OASIS) .......................................... 111 Specialized Treatment in Early Psychosis (Yale STEP) ........................................................................................ 115 Calgary Early Psychosis Treatment Services ....................................................................................................... 119 Bipolar Disorder Early Assessment and Management (BEAM) Program ........................................................... 131 POTENTIAL Outpatient Program Clinic: Early Psychosis and Young Adult Services ........................................... 135 Index ...................................................................................................................................................................... 138 1 Contract No. HHSS283201200002I/Task Order No. HHSS28342002T Updated: October 2017 Note Regarding 2017 Update: This document was first produced in late 2014. Because of the rapid growth in first episode programming over the past few years, this resource guide has been updated annually. Hyperlinks have been checked, and any that may have become inactive over the past year have been revised. New content has been added under the “Selected Additional Resources” section to capture additional areas of research emerging in the recent peer-reviewed literature and to incorporate listings of new publications and archived webinars that have been produced over the past year. Introduction The Fiscal Year 2014 SAMHSA appropriation (part of the Consolidated Appropriations Act, 2014) included a new requirement within the Mental Health Block Grant (MHBG) that “States shall expend at least five percent of the amount each receives… to support evidence-based programs that address the needs of individuals with early serious mental illness, including psychotic disorders, regardless of the age of the individual at onset.” Congress specifically provided an increase to the MHBG over prior-year levels to help states meet this new requirement without losing funds for existing services. In FY 2016, Congress increased the set-aside funding level to 10%, and stipulated that funds be used specifically to address first episode psychosis (FEP). In December, 2016, Congress passed the 21st Century Cures Act, which codified the 10% set-aside and requires that the funding be used “to support evidence-based programs that address the needs of individuals with early serious mental illness, including psychotic disorders, regardless of the age of the individual at onset.” (P.L. 114-255) The set aside was intended to stimulate state programming to better identify and more adequately respond to individuals who are experiencing their first episode of serious mental illness. Earlier and more assertive responses to these individuals are intended to help reduce the disability that these individuals will ultimately experience and to assist them in pursuing their life goals with appropriate treatment and support. Often individuals receiving care, especially from public systems, are required to meet criteria for serious and persistent mental illnesses to access care. Individuals meeting these criteria generally have significant, long-term disabilities. While delivering services for persons with serious and disabling illnesses continues to be an important role for state mental health systems, the development of responsive programming to first episode consumers may eventually reduce the rates at which they become disabled, benefitting both the client and the treatment system. This inventory reviews a variety of programs and practices to address early stages of serious mental disorders, including schizophrenia, bipolar and affective disorders, as well as other serious mental illnesses. A majority of research and program models, both in the United States and internationally, have focused on addressing First Episode Psychosis (FEP), with an emphasis on programs for persons with non-affective psychosis. FEP programs implemented in the United States, Australia, Canada, the United Kingdom, and Scandinavia have been shown to improve symptoms, reduce relapse and prevent deterioration and disability. In the NIMH- supported studies, common components of these FEP programs include practices such as assertive community treatment, psychotherapy, supported employment and education, family education and support, and low dosages of antipsychotic medications all delivered as parts of a Coordinated Specialty Care (CSC) model. The 2 Contract No. HHSS283201200002I/Task Order No. HHSS28342002T Updated: October 2017 inclusion criteria for clinical trials of CSCs have included persons who are ill with non-organic and non-affective psychotic disorders for five or fewer years. CSCs are typically targeted toward individuals ages 12 to 35, and are designed to coordinate existing services, including primary medical care, and to eliminate service gaps based on age group. They emphasize collaboration with clients to develop shared treatment goals, sometimes employing shared decision-making approaches to address preferences and recovery goals. CSCs coordinate activities with a multi-disciplinary treatment team and often involve family members as key supports. To help states best use the MHBG Set Aside in the most efficacious manner, SAMHSA and the National Institute of Mental Health (NIMH) have reviewed the evidence supporting specific practices as effective in reducing the impacts of the first episodes
Load more

Recommended publications
  • First Episode Psychosis an Information Guide Revised Edition
    First episode psychosis An information guide revised edition Sarah Bromley, OT Reg (Ont) Monica Choi, MD, FRCPC Sabiha Faruqui, MSc (OT) i First episode psychosis An information guide Sarah Bromley, OT Reg (Ont) Monica Choi, MD, FRCPC Sabiha Faruqui, MSc (OT) A Pan American Health Organization / World Health Organization Collaborating Centre ii Library and Archives Canada Cataloguing in Publication Bromley, Sarah, 1969-, author First episode psychosis : an information guide : a guide for people with psychosis and their families / Sarah Bromley, OT Reg (Ont), Monica Choi, MD, Sabiha Faruqui, MSc (OT). -- Revised edition. Revised edition of: First episode psychosis / Donna Czuchta, Kathryn Ryan. 1999. Includes bibliographical references. Issued in print and electronic formats. ISBN 978-1-77052-595-5 (PRINT).--ISBN 978-1-77052-596-2 (PDF).-- ISBN 978-1-77052-597-9 (HTML).--ISBN 978-1-77052-598-6 (ePUB).-- ISBN 978-1-77114-224-3 (Kindle) 1. Psychoses--Popular works. I. Choi, Monica Arrina, 1978-, author II. Faruqui, Sabiha, 1983-, author III. Centre for Addiction and Mental Health, issuing body IV. Title. RC512.B76 2015 616.89 C2015-901241-4 C2015-901242-2 Printed in Canada Copyright © 1999, 2007, 2015 Centre for Addiction and Mental Health No part of this work may be reproduced or transmitted in any form or by any means electronic or mechanical, including photocopying and recording, or by any information storage and retrieval system without written permission from the publisher—except for a brief quotation (not to exceed 200 words) in a review or professional work. This publication may be available in other formats. For information about alterna- tive formats or other CAMH publications, or to place an order, please contact Sales and Distribution: Toll-free: 1 800 661-1111 Toronto: 416 595-6059 E-mail: [email protected] Online store: http://store.camh.ca Website: www.camh.ca Disponible en français sous le titre : Le premier épisode psychotique : Guide pour les personnes atteintes de psychose et leur famille This guide was produced by CAMH Publications.
    [Show full text]
  • “Cat-Gras” Delusion: a Unique Misidentification Syndrome and a Novel Explanation
    Neurocase The Neural Basis of Cognition ISSN: 1355-4794 (Print) 1465-3656 (Online) Journal homepage: http://www.tandfonline.com/loi/nncs20 “Cat-gras” delusion: a unique misidentification syndrome and a novel explanation R. Ryan Darby & David Caplan To cite this article: R. Ryan Darby & David Caplan (2016) “Cat-gras” delusion: a unique misidentification syndrome and a novel explanation, Neurocase, 22:2, 251-256, DOI: 10.1080/13554794.2015.1136335 To link to this article: https://doi.org/10.1080/13554794.2015.1136335 Published online: 14 Jan 2016. Submit your article to this journal Article views: 1195 View related articles View Crossmark data Citing articles: 4 View citing articles Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=nncs20 Download by: [Vanderbilt University Library] Date: 06 December 2017, At: 06:39 NEUROCASE, 2016 VOL. 22, NO. 2, 251–256 http://dx.doi.org/10.1080/13554794.2015.1136335 “Cat-gras” delusion: a unique misidentification syndrome and a novel explanation R. Ryan Darbya,b,c and David Caplana,c aDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA; bDepartment of Neurology, Brigham and Women’s Hospital, Boston, MA, USA; cHarvard Medical School, Boston, MA, USA ABSRACT ARTICLE HISTORY Capgras syndrome is a distressing delusion found in a variety of neurological and psychiatric diseases Received 23 June 2015 where a patient believes that a family member, friend, or loved one has been replaced by an imposter. Accepted 20 December 2015 Patients recognize the physical resemblance of a familiar acquaintance but feel that the identity of that KEYWORDS person is no longer the same.
    [Show full text]
  • Paranoia and Slowed Cognition Ijeoma Ijeaku, MD, MPH, and Melissa Pereau, MD
    Cases That Test Your Skills Paranoia and slowed cognition Ijeoma Ijeaku, MD, MPH, and Melissa Pereau, MD Mr. K, age 45, is paranoid, combative, and agitated. Two weeks How would you ago he sustained chemical abrasions at home. What could be handle this case? Visit CurrentPsychiatry.com causing his altered mental status? to input your answers and see how your colleagues responded CASE Behavioral changes aggressive and combative. He throws chairs at Mr. K, age 45, is brought to the emergency de- his peers and staff on the unit and is placed in partment (ED) by his wife for severe paranoia, physical restraints. He requires several doses combative behavior, confusion, and slowed of IM haloperidol, 5 mg, lorazepam, 2 mg, and cognition. Mr. K tells the ED staff that a chemi- diphenhydramine, 50 mg, for severe agitation. cal abrasion he sustained a few weeks earlier Mr. K is guarded, perseverative, and selectively has spread to his penis, and insists that his mute. He avoids eye contact and has poor penis is retracting into his body. He has tied grooming. He has slow thought processing and a string around his penis to keep it from dis- displays concrete thought process. Prednisone appearing into his body. According to Mr. K’s is discontinued and olanzapine, titrated to 30 wife, he went to an urgent care clinic 2 weeks mg/d, and mirtazapine, titrated to 30 mg/d, are ago after he sustained chemical abrasions started for psychosis and depression. from exposure to cleaning solution at home. Mr. K’s mood and behavior eventually re- The provider at the urgent care clinic started turn to baseline but slowed cognition persists.
    [Show full text]
  • Understanding a First Episode of Psychosis-Caregiver
    UNDERSTANDING A FIRST EPISODE OF PSYCHOSIS Caregiver: Get the Facts What does it mean when a Hearing a health care professional say your youth or health care young adult is experiencing a first episode of psychosis professional says can be confusing. The good news is that the emotions a “first episode and behaviors you have been concerned about are of psychosis”? often symptoms of a treatable disorder. By engaging in treatment and entering recovery, people with psychoses can feel better and can go on to lead productive, meaningful lives. Recovery does not necessarily mean a cure for people experiencing a first episode of psychosis. It does mean that people are actively moving toward wellness. It can be scary at first— “learning your child has a mental health diagnosis. But, once you really think about it, it is no different than learning your child has asthma or diabetes. It is important to talk with a health care provider about You become educated about the treatment options and additional information. Your provider may be a child and adolescent psychiatrist, condition, you find the resources general psychiatrist, psychologist, pediatrician, social and professionals your child worker, or other health care provider. If you are concerned that your youth or young adult is needs to be healthy, and you continue“ experiencing a first episode of psychosis, it is important to love your child just as to seek a thorough evaluation. The evaluation includes talking about their symptoms, blood and urine tests, much as you ever did. potentially a brain scan, and perhaps other tests to —Malisa, Parent ensure there is no underlying medical condition causing the symptoms.
    [Show full text]
  • Default Mode Network Abnormalities in Bipolar Disorder and Schizophrenia
    Psychiatry Research: Neuroimaging 183 (2010) 59–68 Contents lists available at ScienceDirect Psychiatry Research: Neuroimaging journal homepage: www.elsevier.com/locate/psychresns Default mode network abnormalities in bipolar disorder and schizophrenia Dost Öngüra,⁎, Miriam Lundyb,1, Ian Greenhousec,1, Ann K. Shinna, Vinod Menond, Bruce M. Cohena, Perry F. Renshawe aMcLean Hospital, Belmont, MA and Harvard Medical School, Boston, MA, United States bYale University School of Nursing, New Haven, CT, United States cDepartment of Neuroscience, University of California San Diego, La Jolla, CA, United States dDepartment of Psychiatry and Behavioral Sciences and Program in Neuroscience, Stanford University School of Medicine, Stanford, CA, United States eThe Brain Institute, University of Utah School of Medicine, Salt Lake City, UT, United States article info abstract Article history: The default-mode network (DMN) consists of a set of brain areas preferentially activated during internally Received 15 November 2009 focused tasks. We used functional magnetic resonance imaging (fMRI) to study the DMN in bipolar mania and Received in revised form 6 April 2010 acute schizophrenia. Participants comprised 17 patients with bipolar disorder (BD), 14 patients with Accepted 10 April 2010 schizophrenia (SZ) and 15 normal controls (NC), who underwent 10-min resting fMRI scans. The DMN was extracted using independent component analysis and template-matching; spatial extent and timecourse were Keywords: examined. Both patient groups showed reduced DMN connectivity in the medial prefrontal cortex (mPFC) (BD: Independent component analysis − − − Mania x= 2, y=54, z= 12; SZ: x= 2, y=22, z=18). BD subjects showed abnormal recruitment of parietal Anterior cingulate cortex cortex (correlated with mania severity) while SZ subjects showed greater recruitment of the frontopolar cortex/ Basal ganglia basal ganglia.
    [Show full text]
  • Health Anxiety and Hypochondriasis in the Light of DSM-5 Josef Bailera*, Tobias Kerstner A, Michael Witthöft B, Carsten Diener C,D , Daniela Mier a and Fred Rist E
    Erschienen in: Anxiety, Stress, & Coping ; 29 (2016), 2. - S. 219-239 https://dx.doi.org/10.1080/10615806.2015.1036243 Health anxiety and hypochondriasis in the light of DSM-5 Josef Bailera*, Tobias Kerstner a, Michael Witthöft b, Carsten Diener c,d , Daniela Mier a and Fred Rist e aDepartment of Clinical Psychology, Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany; bDepartment of Clinical Psychology, Johannes Gutenberg University, Mainz, Germany; cSchool of Applied Psychology, SRH University of Applied Sciences, Heidelberg, Germany; dDepartment of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany; eDepartment of Clinical Psychology, University of Münster, Münster, Germany Background: In the DSM-5, the diagnosis of hypochondriasis was replaced by two new diagnositic entities: somatic symptom disorder (SSD) and illness anxiety disorder (IAD). Both diagnoses share high health anxiety as a common criterion, but additonal somatic symptoms are only required for SSD but not IAD. Design: Our aim was to provide empirical evidence for the validity of these new diagnoses using data from a case–control study of highly health-anxious ( n = 96), depressed ( n = 52), and healthy (n = 52) individuals. Results: The individuals originally diagnosed as DSM-IV hypochondriasis predominantly met criteria for SSD (74%) and rarely for IAD (26%). Individuals with SSD were more impaired, had more often comorbid panic and generalized anxiety disorders, and had more medical consultations as those with IAD. Yet, no significant differences were found between SSD and IAD with regard to levels of health anxiety, other hypochondriacial characteristics, illness behavior, somatic symptom attributions, and physical concerns, whereas both groups differed signifi- cantly from clinical and healthy controls in all of these variables.
    [Show full text]
  • Stability of CT Scan Findings in Schizophrenia: Results Ofan 8 Year
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.51.2.209 on 1 February 1988. Downloaded from Journal of Neurology, Neurosurgery, and Psychiatry 1988;51:209-213 Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study BARBARA P ILLOWSKY, DENISE M JULIANO, LLEWELLYN B BIGELOW, DANIEL R WEINBERGER From the Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, Washington, DC, USA SUMMARY Earlier cross-sectional studies have suggested that CT findings of ventricular enlarge- ment and increased cortical markings in schizophrenic patients are not progressive, but individual patients have rarely been followed prospectively. Fifteen patients with chronic schizophrenia were rescanned on the same model machine after 7 to 9 years of continuous illness and, in seven cases, of continuous hospitalisation. It was not possible to demonstrate significant changes in either ventricular-brain ratio or frontal atrophy scores. These results suggest that the pathologic process responsible for CT changes in schizophrenia is static and is not affected by 8 years of neuroleptic medication and institutionalisation. guest. Protected by copyright. The presence of ventricular enlargement in some show a correlation between age or duration of illness schizophrenic patients has led to speculation about and ventricular enlargement.5-7 Other CT studies the importance of structural brain pathology in the have shown that lateral ventricular enlargement is pathogenesis of the illness.' 2 This non-specific already present in some schizophreniform patients by finding could arise from focal pathology of the time of their initial admission.8 -10 periventricular structures or could be part of a more Nasrallah et al recently published a preliminary generalised process as seen in a variety ofneurological report in which patients were restudied 3 years after diseases.
    [Show full text]
  • The ICD-10 Classification of Mental and Behavioural Disorders
    The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines World Health Organization -1- Preface In the early 1960s, the Mental Health Programme of the World Health Organization (WHO) became actively engaged in a programme aiming to improve the diagnosis and classification of mental disorders. At that time, WHO convened a series of meetings to review knowledge, actively involving representatives of different disciplines, various schools of thought in psychiatry, and all parts of the world in the programme. It stimulated and conducted research on criteria for classification and for reliability of diagnosis, and produced and promulgated procedures for joint rating of videotaped interviews and other useful research methods. Numerous proposals to improve the classification of mental disorders resulted from the extensive consultation process, and these were used in drafting the Eighth Revision of the International Classification of Diseases (ICD-8). A glossary defining each category of mental disorder in ICD-8 was also developed. The programme activities also resulted in the establishment of a network of individuals and centres who continued to work on issues related to the improvement of psychiatric classification (1, 2). The 1970s saw further growth of interest in improving psychiatric classification worldwide. Expansion of international contacts, the undertaking of several international collaborative studies, and the availability of new treatments all contributed to this trend. Several national psychiatric bodies encouraged the development of specific criteria for classification in order to improve diagnostic reliability. In particular, the American Psychiatric Association developed and promulgated its Third Revision of the Diagnostic and Statistical Manual, which incorporated operational criteria into its classification system.
    [Show full text]
  • Generalized Anxiety Disorder Clinical Practice Guideline
    Magellan’s Clinical Practice Guideline for the Assessment and Treatment of Generalized Anxiety Disorder in Adults ©2008-2018 Magellan Health, Inc. 7/18 This document is the proprietary information of Magellan Health, Inc. and its affiliates. Magellan Clinical Practice Guideline Task Force Deborah Heggie, Ph.D. Gary M. Henschen, M.D., L.F.A.P.A. Louis A. Parrott, M.D., Ph.D. Mary Shorter, LCSW-C. Table of Contents Purpose of This Document ............................................................................. 3 Provider Feedback .......................................................................................... 3 Executive Summary ....................................................................................... 4 Generalized Anxiety Disorder in Adults Assessment ........................................................................................... 12 Diagnosis and Treatment Planning ......................................................... 18 Management of Patient Including Patient/Family Education ................... 18 Psychotherapy Treatments ..................................................................... 19 Pharmacology Treatments ...................................................................... 28 Combined Treatments ............................................................................ 47 Monitor Progress and Address Sub-optimal Recovery ............................. 50 References ................................................................................................... 52 2 ©2008-2018
    [Show full text]
  • Neuroimaging and Mental Illness: a Window Into the Brain Frequently Asked Questions About Brain Scans
    Neuroimaging and Mental Illness: A Window Into the Brain Frequently asked questions about brain scans NATIONAL INSTITUTE OF MENTAL HEALTH U.S. Department of Health and Human Services National Institutes of Health rain imaging scans, also called neuroimaging scans, What Brain Scans Can Do are being used more and more to help detect and B Show damage to brain tissue, the skull, or blood diagnose a number of medical disorders and illnesses. vessels in the brain Currently, the main use of brain scans for mental disor- ders is in research studies to learn more about the disor- Be used with other medical tests to help doctors fi nd ders. Brain scans alone cannot be used to diagnose a the right diagnosis for mood and behavioral mental disorder, such as autism, anxiety, depression, problems schizophrenia, or bipolar disorder. Help researchers study healthy brain development, In some cases, a brain scan might be used to rule out effects of mental illnesses or effects of mental health other medical illnesses, such as a tumor, that could treatments on the brain. cause symptoms similar to a mental disorder, such as What Brain Scans Cannot Do depression. Other types of tests are needed for a mental illness to be properly diagnosed. Scientists are studying Diagnose mental illness when used by themselves differences in the brains of people with and without a Predict risk of getting a mental illness. mental illness to learn more about these disorders. How­ ever, at this time relying on brain scans alone cannot accurately diagnose a mental illness or tell you your risk of getting a mental illness in the future.
    [Show full text]
  • Blunted Activation in Orbitofrontal Cortex During Mania: a Functional Magnetic Resonance Imaging Study Lori L
    ORIGINAL ARTICLES Blunted Activation in Orbitofrontal Cortex During Mania: A Functional Magnetic Resonance Imaging Study Lori L. Altshuler, Susan Y. Bookheimer, Jennifer Townsend, Manuel A. Proenza, Naomi Eisenberger, Fred Sabb, Jim Mintz, and Mark S. Cohen Background: Patients with bipolar disorder have been reported to have abnormal cortical function during mania. In this study, we sought to investigate neural activity in the frontal lobe during mania, using functional magnetic resonance imaging (fMRI). Specifically, we sought to evaluate activation in the lateral orbitofrontal cortex, a brain region that is normally activated during activities that require response inhibition. Methods: Eleven manic subjects and 13 control subjects underwent fMRI while performing the Go-NoGo task, a neuropsychological paradigm known to activate the orbitofrontal cortex in normal subjects. Patterns of whole-brain activation during fMRI scanning were determined with statistical parametric mapping. Contrasts were made for each subject for the NoGo minus Go conditions. Contrasts were used in a second-level analysis with subject as a random factor. Results: Functional MRI data revealed robust activation of the right orbitofrontal cortex (Brodmann’s area [BA] 47) in control subjects but not in manic subjects. Random-effects analyses demonstrated significantly less magnitude in signal intensity in the right lateral orbitofrontal cortex (BA 47), right hippocampus, and left cingulate (BA 24) in manic compared with control subjects. Conclusions: Mania is associated with a significant attenuation of task-related activation of right lateral orbitofrontal function. This lack of activation of a brain region that is usually involved in suppression of responses might account for some of the disinhibition seen in mania.
    [Show full text]
  • Trait Paranoia Shapes Inter-Subject Synchrony in Brain Activity During an Ambiguous Social Narrative
    ARTICLE DOI: 10.1038/s41467-018-04387-2 OPEN Trait paranoia shapes inter-subject synchrony in brain activity during an ambiguous social narrative Emily S. Finn 1, Philip R. Corlett2, Gang Chen3, Peter A. Bandettini1 & R. Todd Constable 4 Individuals often interpret the same event in different ways. How do personality traits modulate brain activity evoked by a complex stimulus? Here we report results from a nat- uralistic paradigm designed to draw out both neural and behavioral variation along a specific 1234567890():,; dimension of interest, namely paranoia. Participants listen to a narrative during functional MRI describing an ambiguous social scenario, written such that some individuals would find it highly suspicious, while others less so. Using inter-subject correlation analysis, we identify several brain areas that are differentially synchronized during listening between participants with high and low trait-level paranoia, including theory-of-mind regions. Follow-up analyses indicate that these regions are more active to mentalizing events in high-paranoia individuals. Analyzing participants’ speech as they freely recall the narrative reveals semantic and syn- tactic features that also scale with paranoia. Results indicate that a personality trait can act as an intrinsic “prime,” yielding different neural and behavioral responses to the same stimulus across individuals. 1 Section on Functional Imaging Methods, Laboratory of Brain and Cognition, National Institute of Mental Health, Bethesda, MD 20892-9663, USA. 2 Department of Psychiatry, Yale School of Medicine, New Haven, CT 06511-6662, USA. 3 Scientific and Statistical Computing Core, National Institute of Mental Health, Bethesda, MD 20892-9663, USA. 4 Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT 06520- 8042, USA.
    [Show full text]